|
LOC595101 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.029800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.055110E-03 |
| Normal-vs-Stage2 |
7.349900E-02 |
| Normal-vs-Stage3 |
9.544600E-01 |
| Normal-vs-Stage4 |
4.738200E-01 |
| Stage1-vs-Stage2 |
4.876000E-01 |
| Stage1-vs-Stage3 |
7.60300000000047E-05 |
| Stage1-vs-Stage4 |
1.910180E-02 |
| Stage2-vs-Stage3 |
4.249900E-02 |
| Stage2-vs-Stage4 |
2.354600E-01 |
| Stage3-vs-Stage4 |
4.340800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.139900E-02 |
| Normal-vs-AfricanAmerican |
3.997900E-03 |
| Normal-vs-Asian |
3.178100E-02 |
| Caucasian-vs-AfricanAmerican |
3.936200E-02 |
| Caucasian-vs-Asian |
1.341440E-01 |
| AfricanAmerican-vs-Asian |
5.817800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.956790E-01 |
| Normal-vs-Female |
1.720040E-03 |
| Male-vs-Female |
4.124100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.346600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.043700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.990350E-01 |
| Normal-vs-Age(81-100Yrs) |
7.986000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.662200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.179800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.522400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.324020E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.449800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.897200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.877800E-03 |
| Normal-vs-Grade 2 |
2.580000E-03 |
| Normal-vs-Grade 3 |
2.132000E-01 |
| Normal-vs-Grade 4 |
9.921600E-01 |
| Grade 1-vs-Grade 2 |
1.498630E-01 |
| Grade 1-vs-Grade 3 |
7.701600E-03 |
| Grade 1-vs-Grade 4 |
6.944600E-03 |
| Grade 2-vs-Grade 3 |
1.235510E-02 |
| Grade 2-vs-Grade 4 |
5.899600E-03 |
| Grade 3-vs-Grade 4 |
2.157800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.443820E-03 |
| Normal-vs-ccB subtype |
3.732200E-01 |
| ccA subtype-vs-ccB subtype |
2.079800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.372000E-02 |
| Normal-vs-N1 |
5.957000E-01 |
| N0-vs-N1 |
1.323350E-01 |
|
|
